HORIZON-HLTH-2027-02-DISEASE-14-two-stage:
Clinical trials for advancing innovative interventions for neurodegenerative diseases (RIA)
Deadlines:
geändert: 1st stage: 17.02.2027
geändert: 2nd stage: 16.09.2027
♦ Cross-cutting priorities: SSH, FAIR Data
♦ Type of MGA: Action Grant Budget-Based
♦ Procedure: Blind Evaluation
